Borg L - Search Results

1

Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects.

Bart G, Borg L, Schluger JH, Green M, Ho A, Kreek MJ. Bart G, et al. Among authors: borg l. J Pharmacol Exp Ther. 2003 Aug;306(2):581-7. doi: 10.1124/jpet.103.050682. Epub 2003 May 2. J Pharmacol Exp Ther. 2003. PMID: 12730354 Clinical Trial.

2

The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.

Borg L, Ho A, Wells A, Joseph H, Appel P, Moody D, Kreek MJ. Borg L, et al. J Addict Dis. 2002;21(3):13-22. doi: 10.1300/J069v21n03_02. J Addict Dis. 2002. PMID: 12094997

3

Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?

Bart G, Schluger JH, Borg L, Ho A, Bidlack JM, Kreek MJ. Bart G, et al. Among authors: borg l. Neuropsychopharmacology. 2005 Dec;30(12):2254-62. doi: 10.1038/sj.npp.1300811. Neuropsychopharmacology. 2005. PMID: 15988468

4

Availability of reliable serum methadone determination for management of symptomatic patients.

Borg L, Ho A, Peters JE, Kreek MJ. Borg L, et al. J Addict Dis. 1995;14(3):83-96. doi: 10.1300/J069v14n03_06. J Addict Dis. 1995. PMID: 8555281

5

Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.

Kreek MJ, Schluger J, Borg L, Gunduz M, Ho A. Kreek MJ, et al. Among authors: borg l. J Pharmacol Exp Ther. 1999 Jan;288(1):260-9. J Pharmacol Exp Ther. 1999. PMID: 9862779 Clinical Trial.

6

Acute subjective effects of dynorphin A(1-13) infusion in normal healthy subjects.

King AC, Ho A, Schluger J, Borg L, Kreek MJ. King AC, et al. Among authors: borg l. Drug Alcohol Depend. 1999 Mar 1;54(1):87-90. doi: 10.1016/s0376-8716(98)00150-1. Drug Alcohol Depend. 1999. PMID: 10101621 Clinical Trial.

7

Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.

Schluger JH, Borg L, Ho A, Kreek MJ. Schluger JH, et al. Among authors: borg l. Neuropsychopharmacology. 2001 May;24(5):568-75. doi: 10.1016/S0893-133X(00)00222-0. Neuropsychopharmacology. 2001. PMID: 11282257

8

Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment.

Piccolo P, Borg L, Lin A, Melia D, Ho A, Kreek MJ. Piccolo P, et al. Among authors: borg l. J Addict Dis. 2002;21(4):55-66. doi: 10.1300/J069v21n04_06. J Addict Dis. 2002. PMID: 12296502

9

Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.

Aouizerate B, Ho A, Schluger JH, Perret G, Borg L, Le Moal M, Piazza PV, Kreek MJ. Aouizerate B, et al. Among authors: borg l. Addict Biol. 2006 Mar;11(1):84-96. doi: 10.1111/j.1369-1600.2006.00006.x. Addict Biol. 2006. PMID: 16759341

10

Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene.

Bart G, LaForge KS, Borg L, Lilly C, Ho A, Kreek MJ. Bart G, et al. Among authors: borg l. Neuropsychopharmacology. 2006 Oct;31(10):2313-7. doi: 10.1038/sj.npp.1301128. Epub 2006 Jun 21. Neuropsychopharmacology. 2006. PMID: 16794569 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters